Branowska, D.; Karczmarzyk, Z.; Wolińska, E.; Wysocki, W.; Morawiak, M.; Urbańczyk-Lipkowska, Z.; Bielawska, A.; Bielawski, K.
1,2,4-Triazine Sulfonamides: Synthesis by Sulfenamide Intermediates, In Vitro Anticancer Screening, Structural Characterization, and Molecular Docking Study. Molecules 2020, 25, 2324.
https://doi.org/10.3390/molecules25102324
AMA Style
Branowska D, Karczmarzyk Z, Wolińska E, Wysocki W, Morawiak M, Urbańczyk-Lipkowska Z, Bielawska A, Bielawski K.
1,2,4-Triazine Sulfonamides: Synthesis by Sulfenamide Intermediates, In Vitro Anticancer Screening, Structural Characterization, and Molecular Docking Study. Molecules. 2020; 25(10):2324.
https://doi.org/10.3390/molecules25102324
Chicago/Turabian Style
Branowska, Danuta, Zbigniew Karczmarzyk, Ewa Wolińska, Waldemar Wysocki, Maja Morawiak, Zofia Urbańczyk-Lipkowska, Anna Bielawska, and Krzysztof Bielawski.
2020. "1,2,4-Triazine Sulfonamides: Synthesis by Sulfenamide Intermediates, In Vitro Anticancer Screening, Structural Characterization, and Molecular Docking Study" Molecules 25, no. 10: 2324.
https://doi.org/10.3390/molecules25102324
APA Style
Branowska, D., Karczmarzyk, Z., Wolińska, E., Wysocki, W., Morawiak, M., Urbańczyk-Lipkowska, Z., Bielawska, A., & Bielawski, K.
(2020). 1,2,4-Triazine Sulfonamides: Synthesis by Sulfenamide Intermediates, In Vitro Anticancer Screening, Structural Characterization, and Molecular Docking Study. Molecules, 25(10), 2324.
https://doi.org/10.3390/molecules25102324
